Research Article
Identification and Verification of Molecular Subtypes with Enhanced Immune Infiltration Based on m6A Regulators in Cutaneous Melanoma
Table 2
Different CNV patterns occur in CM patients.
| Types | Genes | Diploid | Deletion | Amplification | CNV sum | Amplification (%) | Deletion (%) | Percentage |
| Writers | METTL3 | 338 | 93 | 40 | 133 | 30.08% | 69.92% | 28.24% | METTL14 | 354 | 76 | 41 | 117 | 35.04% | 64.96% | 24.84% | WTAP | 203 | 246 | 24 | 270 | 8.89% | 91.11% | 57.08% | KIAA1429 | 268 | 10 | 194 | 204 | 95.10% | 4.90% | 43.22% | RBM15 | 236 | 70 | 75 | 145 | 51.72% | 48.28% | 38.06% | ZC3H13 | 303 | 76 | 92 | 168 | 54.76% | 45.24% | 35.67% | Readers | YTHDC1 | 361 | 68 | 52 | 120 | 43.33% | 56.67% | 24.95% | YTHDC2 | 324 | 100 | 47 | 147 | 31.97% | 68.03% | 31.21% | YTHDF3 | 282 | 14 | 175 | 189 | 92.59% | 7.41% | 40.13% | YTHDF1 | 271 | 3 | 198 | 201 | 98.51% | 1.49% | 42.58% | YTHDF2 | 346 | 55 | 70 | 125 | 56.00% | 44.00% | 26.54% | HNRNPC | 338 | 93 | 40 | 133 | 30.08% | 69.92% | 28.24% | IGF2BP1 | 3342 | 43 | 90 | 133 | 67.67% | 32.33% | 3.83% | IGF2BP2 | 358 | 51 | 62 | 113 | 54.87% | 45.13% | 23.99% | IGF2BP3 | 228 | 18 | 230 | 248 | 92.74% | 7.26% | 52.10% | Erasers | FTO | 329 | 116 | 36 | 152 | 23.68% | 76.32% | 31.60% | ALKBH5 | 336 | 209 | 26 | 235 | 11.06% | 88.94% | 41.16% | Total | | 8217 | 1341 | 1492 | 2833 | 52.67% | 47.33% | 25.64% |
|
|